These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 19329424

  • 1. Short-term changes in magnetic resonance imaging and disease activity in response to infliximab.
    Bonel HM, Boller C, Saar B, Tanner S, Srivastav S, Villiger PM.
    Ann Rheum Dis; 2010 Jan; 69(1):120-5. PubMed ID: 19329424
    [Abstract] [Full Text] [Related]

  • 2. Responsiveness of the Ankylosing Spondylitis Disease Activity Score (ASDAS) and clinical and MRI measures of disease activity in a 1-year follow-up study of patients with axial spondyloarthritis treated with tumour necrosis factor alpha inhibitors.
    Pedersen SJ, Sørensen IJ, Hermann KG, Madsen OR, Tvede N, Hansen MS, Thamsborg G, Andersen LS, Majgaard O, Loft AG, Erlendsson J, Asmussen K, Johansen JS, Jurik AG, Møller J, Hasselquist M, Mikkelsen D, Skjødt T, Hansen A, Ostergaard M.
    Ann Rheum Dis; 2010 Jun; 69(6):1065-71. PubMed ID: 19740906
    [Abstract] [Full Text] [Related]

  • 3. Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis, before and after successful therapy with infliximab: evaluation of a new scoring system.
    Braun J, Baraliakos X, Golder W, Brandt J, Rudwaleit M, Listing J, Bollow M, Sieper J, Van Der Heijde D.
    Arthritis Rheum; 2003 Apr; 48(4):1126-36. PubMed ID: 12687557
    [Abstract] [Full Text] [Related]

  • 4. Persistent reduction of spinal inflammation as assessed by magnetic resonance imaging in patients with ankylosing spondylitis after 2 yrs of treatment with the anti-tumour necrosis factor agent infliximab.
    Sieper J, Baraliakos X, Listing J, Brandt J, Haibel H, Rudwaleit M, Braun J.
    Rheumatology (Oxford); 2005 Dec; 44(12):1525-30. PubMed ID: 16091396
    [Abstract] [Full Text] [Related]

  • 5. Magnetic resonance imaging of the spine and the sacroiliac joints in ankylosing spondylitis and undifferentiated spondyloarthritis during treatment with etanercept.
    Rudwaleit M, Baraliakos X, Listing J, Brandt J, Sieper J, Braun J.
    Ann Rheum Dis; 2005 Sep; 64(9):1305-10. PubMed ID: 15778243
    [Abstract] [Full Text] [Related]

  • 6. ASDAS, BASDAI and different treatment responses and their relation to biomarkers of inflammation, cartilage and bone turnover in patients with axial spondyloarthritis treated with TNFα inhibitors.
    Pedersen SJ, Sørensen IJ, Garnero P, Johansen JS, Madsen OR, Tvede N, Hansen MS, Thamsborg G, Andersen LS, Majgaard O, Loft AG, Erlendsson J, Asmussen K, Jurik AG, Møller J, Hasselquist M, Mikkelsen D, Skjødt T, Lambert R, Hansen A, Østergaard M.
    Ann Rheum Dis; 2011 Aug; 70(8):1375-81. PubMed ID: 21551511
    [Abstract] [Full Text] [Related]

  • 7. The percentage of patients with seronegative spondyloarthritis requiring magnetic resonance imaging to meet the Canadian Rheumatology Association/Spondyloarthritis Research Consortium of Canada guidelines for access to anti-tumor necrosis factor treatment.
    Troppmann L, Karsh J, Canadian Rheumatology Association/Spondyloarthritis Research Consortium of Canada.
    J Rheumatol; 2008 Apr; 35(4):658-61. PubMed ID: 18278833
    [Abstract] [Full Text] [Related]

  • 8. Effect of golimumab and pamidronate on clinical efficacy and MRI inflammation in axial spondyloarthritis: a 48-week open randomized trial.
    Mok CC, Li OC, Chan KL, Ho LY, Hui PK.
    Scand J Rheumatol; 2015 Apr; 44(6):480-6. PubMed ID: 26271141
    [Abstract] [Full Text] [Related]

  • 9. Magnetic resonance imaging assessment of spinal inflammation in patients treated for ankylosing spondylitis.
    Treitl M, Korner M, Becker-Gaab C, Tryzna M, Rieger J, Pfeifer KJ, Reiser MF, Wirth S.
    J Rheumatol; 2008 Jan; 35(1):126-36. PubMed ID: 18061979
    [Abstract] [Full Text] [Related]

  • 10. MRI in predicting a major clinical response to anti-tumour necrosis factor treatment in ankylosing spondylitis.
    Rudwaleit M, Schwarzlose S, Hilgert ES, Listing J, Braun J, Sieper J.
    Ann Rheum Dis; 2008 Sep; 67(9):1276-81. PubMed ID: 18006539
    [Abstract] [Full Text] [Related]

  • 11. Inflammatory biomarkers, disease activity and spinal disease measures in patients with ankylosing spondylitis after treatment with infliximab.
    Visvanathan S, Wagner C, Marini JC, Baker D, Gathany T, Han J, van der Heijde D, Braun J.
    Ann Rheum Dis; 2008 Apr; 67(4):511-7. PubMed ID: 17644552
    [Abstract] [Full Text] [Related]

  • 12. Serum biomarkers and changes in clinical/MRI evidence of golimumab-treated patients with ankylosing spondylitis: results of the randomized, placebo-controlled GO-RAISE study.
    Inman RD, Baraliakos X, Hermann KA, Braun J, Deodhar A, van der Heijde D, Xu S, Hsu B.
    Arthritis Res Ther; 2016 Dec 28; 18(1):304. PubMed ID: 28031053
    [Abstract] [Full Text] [Related]

  • 13. Both structural damage and inflammation of the spine contribute to impairment of spinal mobility in patients with ankylosing spondylitis.
    Machado P, Landewé R, Braun J, Hermann KG, Baker D, van der Heijde D.
    Ann Rheum Dis; 2010 Aug 28; 69(8):1465-70. PubMed ID: 20498215
    [Abstract] [Full Text] [Related]

  • 14. Brief Report: Six-Week Treatment of Axial Spondyloarthritis Patients With an Optimal Dose of Nonsteroidal Antiinflammatory Drugs: Early Response to Treatment in Signal Intensity on Magnetic Resonance Imaging of the Sacroiliac Joints.
    Varkas G, Jans L, Cypers H, Van Praet L, Carron P, Elewaut D, Van den Bosch F.
    Arthritis Rheumatol; 2016 Mar 28; 68(3):672-8. PubMed ID: 26473982
    [Abstract] [Full Text] [Related]

  • 15. Radiographic progression is associated with resolution of systemic inflammation in patients with axial spondylarthritis treated with tumor necrosis factor α inhibitors: a study of radiographic progression, inflammation on magnetic resonance imaging, and circulating biomarkers of inflammation, angiogenesis, and cartilage and bone turnover.
    Pedersen SJ, Sørensen IJ, Lambert RG, Hermann KG, Garnero P, Johansen JS, Madsen OR, Hansen A, Hansen MS, Thamsborg G, Andersen LS, Majgaard O, Loft AG, Erlendsson J, Asmussen KH, Jurik AG, Møller J, Hasselquist M, Mikkelsen D, Østergaard M.
    Arthritis Rheum; 2011 Dec 28; 63(12):3789-800. PubMed ID: 22127697
    [Abstract] [Full Text] [Related]

  • 16. Clinical and imaging efficacy of infliximab in HLA-B27-Positive patients with magnetic resonance imaging-determined early sacroiliitis.
    Barkham N, Keen HI, Coates LC, O'Connor P, Hensor E, Fraser AD, Cawkwell LS, Bennett A, McGonagle D, Emery P.
    Arthritis Rheum; 2009 Apr 28; 60(4):946-54. PubMed ID: 19333933
    [Abstract] [Full Text] [Related]

  • 17. Long-term outcome of anti-tumor necrosis factor alpha blockade in the treatment of juvenile spondyloarthritis.
    Hugle B, Burgos-Vargas R, Inman RD, O'Shea F, Laxer RM, Stimec J, Whitney-Mahoney K, Duvnjak M, Anderson M, Tse SM.
    Clin Exp Rheumatol; 2014 Apr 28; 32(3):424-31. PubMed ID: 24387974
    [Abstract] [Full Text] [Related]

  • 18. Consistently Good clinical response in patients with early axial spondyloarthritis after 3 years of continuous treatment with etanercept: longterm data of the ESTHER trial.
    Song IH, Hermann KG, Haibel H, Althoff CE, Poddubnyy D, Listing J, Weiß A, Buß B, Freundlich B, Lange E, Alten R, Rudwaleit M, Sieper J.
    J Rheumatol; 2014 Oct 28; 41(10):2034-40. PubMed ID: 25028375
    [Abstract] [Full Text] [Related]

  • 19. Infliximab in combination with methotrexate in active ankylosing spondylitis: a clinical and imaging study.
    Marzo-Ortega H, McGonagle D, Jarrett S, Haugeberg G, Hensor E, O'connor P, Tan AL, Conaghan PG, Greenstein A, Emery P.
    Ann Rheum Dis; 2005 Nov 28; 64(11):1568-75. PubMed ID: 15829577
    [Abstract] [Full Text] [Related]

  • 20. Local infliximab injection of sacroiliac joints in non-radiographic axial spondyloarthritis: Impact on clinical and magnetic resonance imaging parameters of disease activity.
    Soliman E, El-Tantawi G, Matrawy K, Aldawoudy A, Naguib A.
    Mod Rheumatol; 2015 May 28; 25(3):421-6. PubMed ID: 25401227
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.